NHWA(SZ:002262) Sou Hu Cai Jing·2025-10-25 00:14Core Insights - Enhua Pharmaceutical (002262.SZ) released its Q3 2025 report on October 25, 2025, indicating a total of 356 million shares held by institutional investors, accounting for 35.08% of the company's total equity [1] - The institutional holding percentage decreased by 2.55 percentage points compared to the previous quarter [1] Institutional Holdings - Five institutional investors disclosed their holdings in Enhua Pharmaceutical, including Xuzhou Enhua Investment Co., Hong Kong Central Clearing Limited, and two national social security fund combinations [1] - One new public fund was disclosed this quarter, while 323 public funds were not disclosed compared to the previous quarter [1] Social Security Fund - Two new social security funds disclosed their holdings in Enhua Pharmaceutical, while one fund was not disclosed compared to the previous quarter [1] Foreign Investment - One new foreign institution, Hong Kong Central Clearing Limited, disclosed its holdings this quarter [1]